Blosozumab
Encyclopedia
Blosozumab binds SOST
, a negative regulator of osteoblast activity. Blocking SOST activity can lead to increased bone density.
Blosozumab was developed by Eli Lilly and Company
.
SOST
Sclerostin is a protein that in humans is encoded by the SOST gene.-External links:*-Further reading:...
, a negative regulator of osteoblast activity. Blocking SOST activity can lead to increased bone density.
Blosozumab was developed by Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company is a global pharmaceutical company. Eli Lilly's global headquarters is located in Indianapolis, Indiana, in the United States...
.